Mirum Pharmaceuticals, Inc.
950 Tower Lane,
Foster City, 94404, CA,
United States
Foster City, 94404, CA,
United States
1 972-444-9001
Life Sciences
Mirum Pharmaceuticals, Inc. Technographics
Mirum Pharmaceuticals, Inc. Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Mirum Pharmaceuticals, Inc. and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 137 Mirum Pharmaceuticals, Inc. employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Mirum Pharmaceuticals, Inc. has purchased the following applications: NAVLIN Price & Access Software (formerly PriceRight by EVERSANA) for Price Optimization in 2020, Microsoft 365 for Collaboration in 2019, DocuSign eSignature for Digital Signing in 2021 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Mirum Pharmaceuticals, Inc. is running and its propensity to invest more and deepen its relationship with EVERSANA , Microsoft , DocuSign or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Mirum Pharmaceuticals, Inc. revenues, which have grown to $19.1 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Mirum Pharmaceuticals, Inc. intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Mirum Pharmaceuticals, Inc. Tech Stack and Enterprise Applications
Mirum Pharmaceuticals, Inc. ERP Services and Operations
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| EVERSANA | Legacy | NAVLIN Price & Access Software (formerly PriceRight by EVERSANA) | Price Optimization | ERP Services and Operations | n/a | 2020 | 2020 |
In 2020, Mirum Pharmaceuticals, Inc. engaged EVERSANA to support U.S. commercialization of maralixibat and implemented NAVLIN Price & Access Software, formerly PriceRight by EVERSANA, to address Price Optimization requirements. The engagement explicitly covered U.S. market access, distribution and pricing support for the product launch, and the NAVLIN Price & Access Software was applied as the pricing and access layer for those commercialization activities.
The NAVLIN Price & Access Software deployment concentrated on Price Optimization functional capabilities common to the category, including price setting and scenario modeling, list versus net price simulations, payer segmentation and contract lifecycle management. Configuration work emphasized pricing rule definitions, scenario comparison and price-impact analytics to support cross-functional decision making between commercial and market access teams.
Operational coverage was focused on the United States launch of maralixibat, impacting commercial pricing, market access, distribution planning and reimbursement strategy functions. The software was used to operationalize pricing decisions within commercialization workflows and to align market access tactics with distribution and payer engagement plans for the U.S. market.
The engagement began in October 2020 with EVERSANA providing market access and distribution services alongside pricing support, and governance centered on cross-functional pricing approvals and coordinated market access workflows to support launch execution. Mirum Pharmaceuticals, Inc., NAVLIN Price & Access Software, Price Optimization and the companys market access and pricing teams were the primary elements of the implementation narrative.
|
Mirum Pharmaceuticals, Inc. Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2019 | 2019 |
In 2019, Mirum Pharmaceuticals, Inc. implemented Microsoft 365 to establish a Collaboration platform across the organization. The deployment positioned Microsoft 365 as the primary Collaboration layer for email, file collaboration, and real time communications at the 137 employee life sciences company.
The Microsoft 365 implementation leverages standard Collaboration capabilities, configured around Exchange Online for enterprise email, SharePoint Online for centralized document management and controlled content libraries, Microsoft Teams for synchronous and asynchronous communications, and OneDrive for endpoint file synchronization. Administration is organized at the tenant level with role based access and centralized policy controls to support compliance minded information governance and cross functional workflows, and Mirum Pharmaceuticals, Inc. is using Microsoft 365 on their website which aligns the public footprint with the internal Collaboration environment.
|
Mirum Pharmaceuticals, Inc. Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| DocuSign | Legacy | DocuSign eSignature | Digital Signing | Content Management | n/a | 2021 | 2021 |
In 2021, Mirum Pharmaceuticals, Inc. implemented DocuSign eSignature as a Digital Signing capability on its public website. The deployment of DocuSign eSignature is implemented as an embedded, website-facing signing layer to capture legally binding signatures and digital consent, using envelope workflows and audit trail functionality to record signer identity and timestamps.
The implementation centers on standard Digital Signing modules such as signature capture, envelope management, authentication controls, and tamper-evident audit logs, integrated directly into web forms and document delivery flows. This configuration positions the DocuSign eSignature implementation to support customer-facing agreement execution and online consent capture, while surfacing system-level controls used for regulatory recordkeeping and electronic evidence of execution.
|
Mirum Pharmaceuticals, Inc. CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Sales Automation, CRM, Sales Engagement | CRM |
|
2021 | 2021 |
|
Mirum Pharmaceuticals, Inc. PaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Transactional Email | PaaS |
|
2021 | 2021 |
|
Mirum Pharmaceuticals, Inc. IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2019 | 2019 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2021 | 2021 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2020 | 2020 |
|
IT Decision Makers and Key Stakeholders at Mirum Pharmaceuticals, Inc.
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Mirum Pharmaceuticals, Inc. Executives
APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Mirum Pharmaceuticals, Inc. IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Mirum Pharmaceuticals, Inc. digital transformation priorities and AI adoption trends.
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||
FAQ - APPS RUN THE WORLD Mirum Pharmaceuticals, Inc. Technographics
Mirum Pharmaceuticals, Inc. is a Life Sciences organization based in United States,
with around 137 employees and annual revenues of $19.1 million.
Mirum Pharmaceuticals, Inc. operates a diverse technology stack with applications such as
NAVLIN Price & Access Software (formerly PriceRight by EVERSANA), Microsoft 365 and DocuSign eSignature,
covering areas like Price Optimization, Collaboration and Digital Signing.
Mirum Pharmaceuticals, Inc. has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as EVERSANA, Microsoft and DocuSign.
Mirum Pharmaceuticals, Inc. recently adopted applications including
DocuSign eSignature in 2021, Salesforce Sales Cloud in 2021 and Intuit Mailchimp Mandrill in 2021,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Mirum Pharmaceuticals, Inc.’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates Mirum Pharmaceuticals, Inc.’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Mirum Pharmaceuticals, Inc. technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.